Sure. This legislation doesn't deal primarily with counterfeiting; it deals primarily with ambush marketing. That's the stated intent. The term isn't found in the legislation, but that's the impact.
IPIC does strongly support laws that improve Canada's international position, which is seen in the eyes of many as to be insufficient insofar as it deals with protection against counterfeiting, but this act deals with a lot of business activities that clearly have nothing to do with counterfeiting; they have to do with support for Olympic athletes or support for teens. It's with respect to those comments that we have been focusing.
With respect to irreparable harm, the situation for patented medicines is a very special regime that supports a very strong position of Canada to provide medicine at the lowest possible cost. It's fundamental to Canada's socialized medicine. I think the situation we're dealing with here with respect to business interests and the rights of athletes and small businesses has nothing to do with that.
The tests for irreparable harm that we're talking about here are the tests available to any other person who's coming into court asking for the type of relief that is available in this legislation. The type of relief in the patented medicines position is related to a completely different regime.